Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Notes Payables (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Notes Payables readings, the most recent being $111721.0 for Q1 2026.

  • On a quarterly basis, Notes Payables changed N/A to $111721.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $111721.0, a N/A change, with the full-year FY2025 number at $9182.0, changed N/A from a year prior.
  • Notes Payables reached $111721.0 in Q1 2026 per CBIH's latest filing, up from $101.0 in the prior quarter.
  • The five-year high for Notes Payables was $151267.0 in Q4 2023, with the low at $101.0 in Q4 2025.
  • A 4-year average of $57821.2 and a median of $9182.0 in 2025 define the central range for Notes Payables.
  • Year-over-year, Notes Payables crashed 98.52% in 2024 and then plummeted 94.35% in 2025.
  • Year by year, Notes Payables stood at $151267.0 in 2023, then crashed by 98.52% to $2236.0 in 2024, then plummeted by 95.48% to $101.0 in 2025, then surged by 110514.85% to $111721.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Notes Payables are $111721.0 (Q1 2026), $101.0 (Q4 2025), and $6363.0 (Q3 2025).